Combining Immunology with Engineering
VaxDesign is an emerging biotechnology company that combines immunology with engineering to find elegant, practical solutions to complex biological problems. We develop, manufacture, and market in vitro assays of the human immune system that are functionally equivalent to the human immune system, and will predict human responses to pharmaceuticals and vaccines much better than existing approaches. Our assays are high-throughput, cost-effective, quantitative, and predictive of human immunological outcomes.
Learn more about our immunotherapy testing technology
BioWorld includes VaxDesign as one of the most innovative companies in biotechnology
The publishers of BioWorld Today have released Innovations in Biotechnology 2008: Development-Stage Companies and Scientific Findings Leading the Way - an executive report focusing on innovative companies leading a new wave of development, and the scientific discoveries that will underpin the next wave of advances. VaxDesign is among the 217 companies listed.
Putting Human Immunity in a Test Tube
TIME Magazine profiled VaxDesign's MIMIC™ technology, its advantages, and our work with IAVI on an AIDS vaccine in their article, Putting Human Immunity in a Test Tube.
VaxDesign Receives Prestigious R&D 100 Award
VaxDesign Corporation announced today that R&D Magazine has named the VaxDesign MIMIC (TM) technology as a recipient of the 2007 R&D 100 Awards.
Contact Us
VaxDesign Corporation12612 Challenger Parkway
Suite 365
Orlando, FL 32826
Main Office
407.249.3650
Fax
407.249.3649
Email